Healthcare -
Biotechnology - NASDAQ - US
$ 20.285
-1.96 %
$ 15 B
Market Cap
-65.44
P/E
SMMT - TOTAL EQUITY
Total Equity SMMT - Summit Therapeutics Inc.
77.7 M
LAST VALUE
-3.42%
2 YEAR CAGR
6.84%
5 YEAR CAGR
25.75%
10 YEAR CAGR